Application of 18 beta-glycyrrhetinic acid in preparation of depression-related neuronal protection medicine
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of neuron protection and glycyrrhetinic acid, which is applied in the field of biomedicine, can solve the problems of lack of development of neuron protection drugs related to depression, and achieve the effect of reducing neuron cell apoptosis, good effect, and no side effects
Pending Publication Date: 2022-03-11
JINAN UNIVERSITY
View PDF3 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] The purpose of this application is to provide an application of 18β-glycyrrhetinic acid in the preparation of neuroprotective drugs related to depression, aiming to solve the problem of lack of corresponding drug development of neuroprotective drugs related to depression in the prior art
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0046] A pharmaceutical composition for treating depression-related neuron protection
[0047] The pharmaceutical composition includes 18β-glycyrrhetinic acid and pharmaceutically acceptable auxiliary agents, wherein the effective concentration of 18β-glycyrrhetinic acid is 10.0 mg / kg.
[0048] Moreover, the dosage form of the pharmaceutical composition is one of tablets, pills, capsules, granules, powders, liquids, emulsions, suspensions, ointments, injections, and skin patches. One or more of agents, binders, emulsifiers, lubricants, glidants, and colorants.
Embodiment 2
[0050] A pharmaceutical composition for treating depression-related neuron protection
[0051] The pharmaceutical composition includes 18β-glycyrrhetinic acid and pharmaceutically acceptable auxiliary agents, wherein the effective concentration of 18β-glycyrrhetinic acid is 20 mg / kg.
[0052] Moreover, the dosage form of the pharmaceutical composition is one of tablets, pills, capsules, granules, powders, liquids, emulsions, suspensions, ointments, injections, and skin patches. One or more of agents, binders, emulsifiers, lubricants, glidants, and colorants.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention belongs to the technical field of biological medicines, and particularly relates to application of 18 beta-glycyrrhetinic acid in preparation of a depression-related neuronal protection medicine. The application specifically comprises the following steps: 18 beta-glycyrrhetinic acid can play a role in protecting neurons by inhibiting depression-related microglial cell activation-mediated neuronal apoptosis; meanwhile, the 18beta-glycyrrhetinic acid can activate a nuclear transcription factor Nrf-2 related to depression to start transcription and translation of a brain-derived nerve growth factor so as to play a role in protecting neuronal cells, and the 18beta-glycyrrhetinic acid is obvious in drug effect and free of obvious side effects.
Description
technical field [0001] The application belongs to the technical field of biomedicine, and in particular relates to the application of 18β-glycyrrhetinic acid in the preparation of neuron protection drugs related to depression treatment. Background technique [0002] Depression is a chronic comprehensive disease with persistent low mood, loss of interest, and decreased will as the core symptoms. It is a common mental disease and has the characteristics of high recurrence rate, high disability rate, and high suicide rate. According to the report of the World Health Organization in 2017, there are 322 million people with depression in the world, the incidence rate is about 4.4%, and there is a problem of recurrent depression and chronicity; depression is also the biggest cause of disability (global depression more than 50 million people are disabled) and are the leading cause of suicide. In my country, there are more than 54 million patients with depression, and the lifetime p...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more